R Mark Adams - Net Worth and Insider Trading

R Mark Adams Net Worth

The estimated net worth of R Mark Adams is at least $1 Million dollars as of 2024-12-13. R Mark Adams is the COO of Adaptive Biotechnologies Corp and owns about 175,361 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $1 Million. Details can be seen in R Mark Adams's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that R Mark Adams has not made any transactions after 2023-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of R Mark Adams

To

R Mark Adams Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, R Mark Adams owns 1 companies in total, including Adaptive Biotechnologies Corp (ADPT) .

Click here to see the complete history of R Mark Adams’s form 4 insider trades.

Insider Ownership Summary of R Mark Adams

Ticker Comapny Transaction Date Type of Owner
ADPT Adaptive Biotechnologies Corp 2023-04-11 Chief Operating Officer

R Mark Adams Latest Holdings Summary

R Mark Adams currently owns a total of 1 stock. R Mark Adams owns 175,361 shares of Adaptive Biotechnologies Corp (ADPT) as of April 11, 2023, with a value of $1 Million.

Latest Holdings of R Mark Adams

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADPT Adaptive Biotechnologies Corp 2023-04-11 175,361 6.16 1,080,224

Holding Weightings of R Mark Adams


R Mark Adams Form 4 Trading Tracker

According to the SEC Form 4 filings, R Mark Adams has made a total of 13 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 3,125 shares on April 11, 2023, which brought R Mark Adams around $26,875.

Insider Trading History of R Mark Adams

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

R Mark Adams Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

R Mark Adams Ownership Network

Ownership Network List of R Mark Adams

No Data

Ownership Network Relation of R Mark Adams

Insider Network Chart

R Mark Adams Owned Company Details

What does Adaptive Biotechnologies Corp do?

Who are the key executives at Adaptive Biotechnologies Corp?

R Mark Adams is the Chief Operating Officer of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include Principal Accounting Officer Kyle Piskel , SVP and General Counsel Stacy L Taylor , and Chief Commercial Ofc Imm Med Sharon Benzeno .

Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary

Over the past 18 months, R Mark Adams made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 220,417 shares made by Tycho Peterson , a net sale of 8,234 shares made by Kyle Piskel , and a net sale of 40,303 shares made by Stacy L Taylor .

In summary, during the past 3 months, insiders sold 248 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 248 shares. During the past 18 months, 429,980 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 429,980 shares.

Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adaptive Biotechnologies Corp Insider Transactions

No Available Data

R Mark Adams Mailing Address

Above is the net worth, insider trading, and ownership report for R Mark Adams. You might contact R Mark Adams via mailing address: C/o Adaptive Biotechnologies Corporation, 1551 Eastlake Ave E Ste 200, Seattle Wa 98102.